Literature DB >> 8606491

The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.

T Murata1, K Nakagawa, A Khalil, T Ishibashi, H Inomata, K Sueishi.   

Abstract

In the retinas of streptozotocin-induced diabetic rats, the relationship between the expression of vascular endothelial growth factor (VEGF) and the breakdown of the blood-retinal barrier (BRB) was investigated. VEGF mRNA expression was examined by in situ hybridization and VEGF protein expression was examined by immunohistochemistry. BRB breakdown was immunohistochemically demonstrated by detecting extravasation of albumin. In diabetic retinas, VEGF mRNA was expressed by the following cells: (a) ganglion cells, (b) glial cells such as astrocytes and Muller cells, whose cell processes are closely associated with retinal vessels, (c) smooth muscle cells and pericytes in the vessel walls, and (d) the retinal pigment epithelium. In diabetic retinas, BRB breakdown was immunohistochemically detected, and VEGF protein expression was markedly increased in comparison to that in the control retinas. The rates of both BRB breakdown and VEGF immunoreactivity increased in proportion to the duration of diabetes. In addition, the rate of BRB breakdown was much higher in vessels with VEGF immunoreactivity than in vessels without VEGF immunoreactivity. These findings indicate that VEGF has a major promoting effect on BRB breakdown in simple diabetic retinopathy. VEGF immunoreactivity was distributed throughout all layers of the retinas, and were most prominently observed in the nerve fiber layer, especially near the optic disc and around large vessels. These two regions coincide with the sites wherein BRB breakdown is clinically detected by fluorescein angiography in diabetic patients. Neovascularization in proliferative diabetic retinopathy is also most commonly observed in these two regions. Because VEGF promotes endothelial proliferation, these findings suggest that VEGF plays a role in the budding of retinal neovascularization and, as a result, could induce proliferative diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606491

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  61 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 2.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 3.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

4.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

5.  Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits.

Authors:  Muh-Shy Chen; Ching-Chung Chang; Chang-Ping Lin; Peng-Chen Wang; Li-Rong Lin; Ping-Kang Hou; Tzyy-Chang Ho
Journal:  J Ocul Pharmacol Ther       Date:  2011-10-19       Impact factor: 2.671

Review 6.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

7.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

8.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

9.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.

Authors:  C Gerhardinger; L F Brown; S Roy; M Mizutani; C L Zucker; M Lorenzi
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 10.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.